EMCURE PHARMACEUTICALS
|
EMCURE PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹8,023 Cr | ₹6,786 Cr | ₹6,098 Cr | ₹5,979 Cr | ₹6,250 Cr |
Sales | ₹7,844 Cr | ₹6,664 Cr | ₹5,986 Cr | ₹5,783 Cr | ₹6,136 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹91 Cr | ₹46 Cr | ₹57 Cr | ₹108 Cr | ₹65 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹88 Cr | ₹76 Cr | ₹55 Cr | ₹89 Cr | ₹50 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹7,896 Cr | ₹6,658 Cr | ₹5,986 Cr | ₹5,855 Cr | ₹6,056 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-264 Cr | ₹-190 Cr | ₹67 Cr | ₹-145 Cr | ₹-253 Cr |
Raw Material Consumed | ₹3,173 Cr | ₹2,447 Cr | ₹2,004 Cr | ₹2,173 Cr | ₹2,604 Cr |
Opening Raw Materials | ₹323 Cr | ₹379 Cr | ₹420 Cr | ₹402 Cr | ₹337 Cr |
Purchases Raw Materials | ₹1,413 Cr | ₹1,059 Cr | ₹916 Cr | ₹1,108 Cr | ₹1,331 Cr |
Closing Raw Materials | ₹447 Cr | ₹323 Cr | ₹379 Cr | ₹420 Cr | ₹402 Cr |
Other Direct Purchases / Brought in cost | ₹1,883 Cr | ₹1,332 Cr | ₹1,047 Cr | ₹1,082 Cr | ₹1,338 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹138 Cr | ₹120 Cr | ₹109 Cr | ₹97 Cr | ₹105 Cr |
Electricity & Power | ₹138 Cr | ₹120 Cr | ₹109 Cr | ₹97 Cr | ₹105 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1,446 Cr | ₹1,292 Cr | ₹1,117 Cr | ₹1,012 Cr | ₹1,102 Cr |
Salaries, Wages & Bonus | ₹1,266 Cr | ₹1,138 Cr | ₹977 Cr | ₹891 Cr | ₹967 Cr |
Contributions to EPF & Pension Funds | ₹92 Cr | ₹74 Cr | ₹64 Cr | ₹59 Cr | ₹68 Cr |
Workmen and Staff Welfare Expenses | ₹68 Cr | ₹59 Cr | ₹52 Cr | ₹41 Cr | ₹45 Cr |
Other Employees Cost | ₹20 Cr | ₹21 Cr | ₹24 Cr | ₹22 Cr | ₹22 Cr |
Other Manufacturing Expenses | ₹589 Cr | ₹505 Cr | ₹451 Cr | ₹478 Cr | ₹408 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹105 Cr | ₹90 Cr | ₹59 Cr | ₹65 Cr | ₹58 Cr |
Repairs and Maintenance | - | - | - | - | - |
Packing Material Consumed | ₹238 Cr | ₹219 Cr | ₹189 Cr | ₹206 Cr | ₹170 Cr |
Other Mfg Exp | ₹247 Cr | ₹196 Cr | ₹202 Cr | ₹207 Cr | ₹180 Cr |
General and Administration Expenses | ₹561 Cr | ₹546 Cr | ₹484 Cr | ₹372 Cr | ₹369 Cr |
Rent , Rates & Taxes | ₹55 Cr | ₹33 Cr | ₹21 Cr | ₹22 Cr | ₹24 Cr |
Insurance | ₹27 Cr | ₹24 Cr | ₹23 Cr | ₹19 Cr | ₹21 Cr |
Printing and stationery | ₹18 Cr | ₹17 Cr | ₹14 Cr | ₹12 Cr | ₹13 Cr |
Professional and legal fees | ₹216 Cr | ₹232 Cr | ₹206 Cr | ₹155 Cr | ₹179 Cr |
Traveling and conveyance | ₹164 Cr | ₹176 Cr | ₹157 Cr | ₹105 Cr | ₹75 Cr |
Other Administration | ₹82 Cr | ₹65 Cr | ₹62 Cr | ₹58 Cr | ₹58 Cr |
Selling and Distribution Expenses | ₹593 Cr | ₹517 Cr | ₹415 Cr | ₹397 Cr | ₹357 Cr |
Advertisement & Sales Promotion | ₹273 Cr | ₹259 Cr | ₹183 Cr | ₹163 Cr | ₹118 Cr |
Sales Commissions & Incentives | ₹145 Cr | ₹130 Cr | ₹103 Cr | ₹90 Cr | ₹55 Cr |
Freight and Forwarding | ₹174 Cr | ₹128 Cr | ₹129 Cr | ₹144 Cr | ₹102 Cr |
Handling and Clearing Charges | - | - | - | - | ₹82 Cr |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹191 Cr | ₹193 Cr | ₹158 Cr | ₹142 Cr | ₹132 Cr |
Bad debts /advances written off | ₹33 Cr | ₹52 Cr | ₹19 Cr | ₹1.96 Cr | ₹2.53 Cr |
Provision for doubtful debts | - | - | ₹5.34 Cr | ₹5.58 Cr | ₹26 Cr |
Losson disposal of fixed assets(net) | - | - | ₹0.33 Cr | ₹0.41 Cr | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹158 Cr | ₹141 Cr | ₹133 Cr | ₹134 Cr | ₹103 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹6,427 Cr | ₹5,429 Cr | ₹4,805 Cr | ₹4,525 Cr | ₹4,824 Cr |
Operating Profit (Excl OI) | ₹1,469 Cr | ₹1,230 Cr | ₹1,181 Cr | ₹1,330 Cr | ₹1,232 Cr |
Other Income | ₹73 Cr | ₹57 Cr | ₹46 Cr | ₹63 Cr | ₹35 Cr |
Interest Received | - | - | ₹12 Cr | ₹10 Cr | ₹7.35 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹38 Cr | ₹7.19 Cr | - | - | ₹0.42 Cr |
Profits on sale of Investments | ₹5.48 Cr | ₹2.32 Cr | ₹0.12 Cr | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹5.52 Cr | ₹13 Cr | ₹19 Cr | ₹37 Cr | ₹15 Cr |
Others | ₹24 Cr | ₹34 Cr | ₹15 Cr | ₹16 Cr | ₹13 Cr |
Operating Profit | ₹1,542 Cr | ₹1,287 Cr | ₹1,227 Cr | ₹1,393 Cr | ₹1,267 Cr |
Interest | ₹176 Cr | ₹237 Cr | ₹214 Cr | ₹176 Cr | ₹198 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹43 Cr | ₹98 Cr | ₹79 Cr | ₹70 Cr | ₹97 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹31 Cr | ₹28 Cr | ₹29 Cr | ₹29 Cr | ₹26 Cr |
Other Interest | ₹102 Cr | ₹111 Cr | ₹106 Cr | ₹77 Cr | ₹76 Cr |
PBDT | ₹1,366 Cr | ₹1,050 Cr | ₹1,013 Cr | ₹1,217 Cr | ₹1,069 Cr |
Depreciation | ₹384 Cr | ₹312 Cr | ₹260 Cr | ₹245 Cr | ₹323 Cr |
Profit Before Taxation & Exceptional Items | ₹982 Cr | ₹737 Cr | ₹753 Cr | ₹973 Cr | ₹746 Cr |
Exceptional Income / Expenses | ₹-10 Cr | ₹-9.93 Cr | ₹-6.15 Cr | - | ₹-89 Cr |
Profit Before Tax | ₹971 Cr | ₹727 Cr | ₹747 Cr | ₹973 Cr | ₹657 Cr |
Provision for Tax | ₹264 Cr | ₹200 Cr | ₹185 Cr | ₹270 Cr | ₹239 Cr |
Current Income Tax | ₹286 Cr | ₹203 Cr | ₹169 Cr | ₹272 Cr | ₹197 Cr |
Deferred Tax | ₹-26 Cr | ₹-12 Cr | ₹12 Cr | ₹-16 Cr | ₹38 Cr |
Other taxes | ₹3.59 Cr | ₹7.98 Cr | ₹3.81 Cr | ₹14 Cr | ₹3.74 Cr |
Profit After Tax | ₹707 Cr | ₹528 Cr | ₹562 Cr | ₹703 Cr | ₹419 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-26 Cr | ₹-29 Cr | ₹-30 Cr | ₹-40 Cr | ₹-26 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹681 Cr | ₹498 Cr | ₹532 Cr | ₹662 Cr | ₹392 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹2,634 Cr | ₹2,196 Cr | ₹1,695 Cr | ₹1,744 Cr | ₹1,369 Cr |
Appropriations | ₹3,315 Cr | ₹2,695 Cr | ₹2,227 Cr | ₹2,406 Cr | ₹1,761 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹2.39 Cr | ₹24 Cr | ₹13 Cr | ₹675 Cr | ₹17 Cr |
Equity Dividend % | - | ₹30.00 | ₹20.00 | ₹30.00 | ₹10.00 |
Earnings Per Share | ₹35.96 | ₹27.50 | ₹29.42 | ₹36.62 | ₹21.68 |
Adjusted EPS | ₹35.96 | ₹27.50 | ₹29.42 | ₹36.62 | ₹21.68 |
Compare Income Statement of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹26,932.7 Cr | 0.9% | 14.3% | 14.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,478.0 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,845.0 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
CIPLA | ₹120,121.0 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 0.9% |
14.3% |
14.2% |
SENSEX | -1.2% |
-3.5% |
-0.5% |
You may also like the below Video Courses